Long‐term decrease in serum N‐terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa
Takeaki Suou, Keiko Hosho, Yukihiro Kishimoto, Yasushi Horie, Hironaka Kawasaki – 1 August 1995 – To evaluate the effect of interferon alfa (IFN‐α) on the hepatic extracellular matrix, we investigated the changes in serum N‐terminal propeptide of type III procollagen during and after 4 months of INF‐α treatment in 178 treated and 45 nontreated patients with chronic hepatitis C. Serum pretreatment levels in nonresponders were significantly higher than those in long‐term and short‐term responders, but those levels were not different in the latter two groups.